Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects

Hypertension Clinical Trial

Official title:

Short Term Effect of Cervical Mobilization vs Manipulation on Blood Pressure in Hypertensive Subjects( Randomized Control Trial)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05420298
• Other study ID #: P.T.REC/012/003253
• Status: Completed
• Phase: N/A
• Start date: June 1, 2022
• Est. completion date: July 4, 2023

Study information

• Verified date: July 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Spinal pain or misalignment is a very common disorder affecting a significant number of populations resulting in substantial disability and economic burden. Various manual therapeutic techniques such as spinal manipulations and mobilizations can be used to treat and manage pain and movement dysfunctions such as spinal malalignments and associated complications. These manual therapeutic techniques can affect the cardiovascular parameters .

-

Description:

Group A group (n=20). All participants will receive only single session of neck mobilization. Grade IV unilateral posteroanterior pressure and sustained extension to be applied restricted joints and muscle energy technique.

• Group B (n=20) will receive single session of neck manipulation with high-velocity, low-amplitude thrust over restricted joints (one at a time) with the goal of restoring normal range of motion in the joint.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: July 4, 2023
• Est. primary completion date: April 20, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 27 Years to 60 Years

Eligibility

Inclusion Criteria:

• SBP ranging from 135 to 159 mm Hg or DBP ranging from 85 to 99 mm Hg over 3 qualifying BP screening visits

• The age of participants will range from 27 to 60 years old.

• Body mass index of participants will range between < 39 kg/m².

Exclusion Criteria:

• cardiovascular diseases or surgery, including second- or third-degree heart block, angina pectoris, defibrillator, valvular disease, recent myocardial infarction, cardiac surgery in the past 12 months.

• history of stroke.

• body mass index (BMI) greater than 39 kg/m2.

• pregnancy.

Related Conditions & MeSH terms

• Hypertension

Intervention

Other:
• cervical mobilization
All participants will receive only single session of cervical mobilization
• cervical manipulation
All participants will receive only single session of cervical manipulation

Locations

Country	Name	City	State
Egypt	Cairo University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	systolic blood pressure measurement	systolic pressure - the pressure when your heart pushes blood out and is measured by Mercury sphygmomanometer and stethoscope	it will be measured immediately before and after single session treatment
Secondary	diastolic blood pressure	the pressure when your heart rests between beats is measured by Mercury sphygmomanometer and stethoscope	it will be measured immediately before and after single session treatment
Secondary	oxygen saturation	Oxygen saturation is a vital parameter to define blood oxygen content and oxygen delivery and is measured by pulse oximetry	it will be measured immediately before and after single session treatment
Secondary	perfusion index	Perfusion index is an indication of the pulse strength at the sensor site. The PI's values range from 0.02% for very weak pulse to 20% for extremely strong pulse.Perfusion index is normally monitored with pulse oximeters	it will be measured immediately before and after single session treatment
Secondary	pain assessment	The visual analog scale (VAS) is a tool widely used to measure pain	it will be measured immediately before and after single session treatment